Literature DB >> 24690553

Adaptation and validation of the Voice Handicap Index in Latvian.

Baiba Trinite1, Janis Sokolovs2.   

Abstract

OBJECTIVES: To establish psychometric indicators of the Voice Handicap Index (VHI) (Latvian version) and their relationship to the psychometric indicators of the original items. STUDY
DESIGN: Parallel group design.
METHODS: The VHI was translated and adapted to Latvian. The translated version of the VHI (Lat-VHI) was completed by 54 patients with voice disorders and by 73 subjects without voice disorders forming the control group. A test-retest group included 54 subjects without voice problems, able to complete the questionnaire twice. The test-retest stability, internal consistency of items of the Lat-VHI, and content and convergent validity of the Latvian version of the VHI were analyzed.
RESULTS: The interclass correlation coefficient ratio of all scales indicated statistically significant (P<0.001) test-retest reliability for the Lat-VHI. High internal consistency was observed among the Lat-VHI total scale (α=.96), functional (α=.92), physical (α=.86), and emotional scale (α=.91) in the patient group. The Pearson moment correlation coefficient indicates a high correlation among the Lat-VHI total scale and subscales (r>0.94), as well as a high correlation among subscales (r>0.81) in the patient group. Convergent validity of the Lat-VHI was determined by comparing the Lat-VHI results with the Voice Disorder Severity scale results. Statistically significant correlation (r=0.78, P<0.001) was discovered in the patient group.
CONCLUSIONS: The Latvian version of the VHI is a psychometrically validated instrument whose indicators correspond to the psychometric indicators of the original sample.
Copyright © 2014 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Quality of life; Subjective evaluation; Voice; Voice Handicap Index

Mesh:

Year:  2014        PMID: 24690553     DOI: 10.1016/j.jvoice.2014.01.008

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  6 in total

1.  The Norwegian Voice Handicap Index (VHI-N) patient scores are dependent on voice-related disease group.

Authors:  Tom Karlsen; John-Helge Heimdal; Anne Rita Hella Grieg; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

2.  Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Anna Sobuś; Agnieszka Wełnicka; Agnieszka Meller; Karolina Machowska-Sempruch; Alicja Zawiślak; Karolina Łuczkowska; Sławomir Milczarek; Bogumiła Osękowska; Edyta Paczkowska; Iwona Rotter; Przemysław Nowacki; Bogusław Machaliński
Journal:  Stem Cells Int       Date:  2019-06-02       Impact factor: 5.443

3.  Checking for voice disorders without clinical intervention: The Greek and global VHI thresholds for voice disordered patients.

Authors:  Dionysios Tafiadis; Spyridon K Chronopoulos; Meropi E Helidoni; Evangelia I Kosma; Louiza Voniati; Periklis Papadopoulos; Thomas Murry; Nafsika Ziavra; George A Velegrakis
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

4.  Polish Translation and Validation of the Voice Handicap Index (VHI-30).

Authors:  Beata Miaśkiewicz; Elżbieta Gos; Małgorzata Dębińska; Aleksandra Panasiewicz-Wosik; Dorota Kapustka; Katarzyna Nikiel; Elżbieta Włodarczyk; Anna Domeracka-Kołodziej; Paulina Krasnodębska; Agata Szkiełkowska
Journal:  Int J Environ Res Public Health       Date:  2022-08-29       Impact factor: 4.614

Review 5.  Functional dysphonia: strategies to improve patient outcomes.

Authors:  Mara Behlau; Glaucya Madazio; Gisele Oliveira
Journal:  Patient Relat Outcome Meas       Date:  2015-12-01

6.  Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Agnieszka Meller; Karolina Machowska-Sempruch; Agnieszka Wełnicka; Edyta Paczkowska; Iwona Rotter; Bogusław Machaliński; Przemysław Nowacki
Journal:  BMC Neurol       Date:  2019-10-19       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.